Data as of May 17
| -0.38 / -0.82%|
The 14 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 51.00, with a high estimate of 60.00 and a low estimate of 44.00. The median estimate represents a +10.89% increase from the last price of 45.99.
The current consensus among 20 polled investment analysts is to Buy stock in Merck & Co Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.